Open AccessA FORGOTTEN GROUP OF ANTIBACTERIAL DRUGS
Author(s) -
Buzel A.Ch.,
Maksimenya G.G.
Publication year - 2021
Publication title -
military medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 67
ISSN - 0026-4075
DOI - 10.51922/2074-5044.2021.4.94
Subject(s) - medicine , antimicrobial , intensive care medicine , antibiotic resistance , anti infective agents , antibiotics , infection control , microbiology and biotechnology , biology
In recent years, considerable attention has been paid to the spread of bacterial resistance to antibiotics, disinfectants, and antiseptics. There are few effective antimicrobial drugs left, the creation of new ones requires significant costs. The WHO defines bacteriophages as a "new therapeutic approach" as an alternative in the fight against bacterial pathogens. Undoubtedly, healthcare organizers, epidemiologists and clinicians currently need an up-to-date assessment of the evidence regarding the benefits, efficacy and safety of bacteriophage therapy, as well as the use of phages for the control and prevention of infections (for example, in a complex of anti-epidemic measures, biological disinfection).